scholarly journals Re: Magone et al.: Ocular adverse effects of infigratinib, a new fibroblast growth factor receptor tyrosine kinase inhibitor (Ophthalmology. 2021;128:624–626)

Ophthalmology ◽  
2021 ◽  
Author(s):  
Jasmine H. Francis ◽  
Julia Canestraro ◽  
David H. Abramson
2007 ◽  
Vol 17 (17) ◽  
pp. 4812-4818 ◽  
Author(s):  
Naparat Kammasud ◽  
Chantana Boonyarat ◽  
Satoshi Tsunoda ◽  
Hiroaki Sakurai ◽  
Ikuo Saiki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document